Aarti Drugs

Historical price data

Aarti Drugs' mission is to be a trusted global provider of high-quality, regulatory-compliant pharmaceutical building blocks. Its key achievement is establishing world-leading production scale for several essential APIs, including Fluconazole, Tinidazole, Metformin HCL, Metronidazole, and Ketoconazole. The company's strategy is centered on vertical integration, continuous process innovation, and capacity expansion—recently exemplified by its new Amines Manufacturing Unit—to solidify its position as a low-cost, high-volume supplier to formulation companies worldwide.

A vertically integrated chemical manufacturing platform specializing in advanced synthesis, process optimization, and scalable production of generic APIs, pharmaceutical intermediates, and specialty chemicals, with embedded global regulatory compliance.

Competes on scale, cost, and quality with large Indian API manufacturers (e.g., Divi's Labs, Laurus Labs) and Chinese chemical giants. Its vertical integration and world-leading production scale in key molecules provide a competitive moat, but the sector remains intensely price-sensitive.